First product launched with Remora® technology to control harmful biofilms at IDS dental trade fare, Germany

Today at the IDS dental trade fare in Cologne, Pro3dure Medical GmbH have launched a 3D printable polymer containing Remora® for use in the construction of dental reliners that helps control harmful biofilms.

The PrintoDent® GR-10 resin incorporated with RemoraR is being made available for use in 3D printed dental liners and dental blanks. The 3D printable dental market is estimated to be worth $3.2 billion in 2022 and is growing at 20.2% CAGR from 2022-2027.

Commenting, Dr Yvonne Davies, Head of Business Development for Penrhos Bio Ltd said ‘We announced our collaboration with Pro3dure Medical in 2022 and the team have done a great job incorporating RemoraR into their 3D printable resins. We look forward to commercial success across our divisions during 2023.’

Dr Martin Klare, CEO of Pro3dure Medical said ‘What Remora® offers us is a unique and patented approach to controlling harmful biofilms. Applying this in our Multi-Species Inhibition (MISR) product range allows us to offer our functional 3D printed dental materials.’

Remora® is inspired by the natural biology of the oceans and helps keep surfaces cleaner for longer. The technology has been developed over many years in Unilever and was recently licensed exclusively to Penrhos Bio Ltd for wider commercialisation beyond homecare applications.

Further Information 

REMORA

https://www.pro3dure.com/en/

https://www.pro3dure.com/en/

Penrhos Bio is currently undertaking a Series A investment raise. This investment will accelerate our regulatory roadmap for the Remora™ technology and unlocks a number of higher value markets such as marine fouling and human healthcare. It also empowers our commercial partners to fully leverage the value of the technology in their products, opening new opportunities and segments.

We will be closing this round in the first half of 2023. If you interested in joining us as an investment partner, please contact our Chief Commercial Officer, Dr Steve Howell; cco@remora.bio

Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials

Through our licence partner in the dental field, (Jernberg Biotechnology), Penrhos Bio has formed a new and exciting partnership with Pro3dure Medical. Pro3dure are world leading in 3D printing technology for medical devices, including in the dental space. https://www.pro3dure.com.

Working closely with Penrhos Bio, and leveraging the R&D expertise of our technical team in Unilever, Pro3dure are developing and launching their new product, MIS, which incorporates our Remora™️ technology.

Quote from Richard Hammond CEO of Penrhos Bio:

We are thrilled to be working with our colleagues at Pro3dure Medical to combine the power of  Remora™️ technology with their world leading expertise in material development. The result is a completely novel way of inhibiting the formation of harmful multispecies biofilms in their MIS products. Remora™️  is inspired by the natural biology certain seaweeds have developed which enables them to block communication between microorganisms. The result is a surface that remains clean and free of biofilms. Backed by Unilever, we have proven efficacy in a wide range of applications, and we are really excited to bring this benefit into dental markets through the innovation of Pro3dure, an ideal partnership. 

Earthbound are our brand partners, and are behind our new branding

Brand Launch 

Thanks to our Partners in Earthbound Brands, Remora™ becomes our brand name, logo and the face of Penrhos Bio. Supported by the ‘Cleaner by Nature’ tagline, the new Remora name will flow through onto products in our customers hands. Distinct and clean, the Remora name and logo will help build the recognition of the technology across multiple and diverse markets from consumer goods to healthcare. The name Remora will become a mark of quality and confidence for our customers and end users alike. In controlling harmful biofilms, ‘Remora™ inside’ will drive customer choice.

The development of the name, logo and brand collaterals reflect the origins of how our technology was inspired by the natural biology of the oceans:

The Remora fish live in harmony with larger sea creatures such as turtles, manta rays and sharks, to name a few. The Remora fish hitch a ride and act as cleaners, gently keeping their host’s surfaces clean of harmful bacteria and algae, (as surface biofilms), whilst doing no harm. Nature is our inspiration, and the Remora name encapsulates that vision of a new generation of more natural and bioinspired solutions for a world free of harmful biofilms. We learn from, and work with, nature, to address this serious global challenge.

The ‘O’ of the Remora logo represents the ring of protection, and the colours of that O have a broader palate to reflect and identify the different divisions within our business model. 

We will build our Brand in both B2B and B2C sectors, with our first brand launch in Q2 2023.

We aim to be the leading Brand in sustainable anti-biofilm technology, the Remora™ logo becoming a Trustmark in the field.

REMORA^TM – CLEANER BY NATURE

Penrhos Bio raise £1m Seed funding to accelerate development of the Remora™️ technology, and is joined as an investment partner by Eos Advisory.

Penrhos Bio has secured the second tranche of its £1m Seed funding round, and is pleased to welcome Eos Advisory as investment partners. This investment, including the first tranche in 2021, takes the business through to its Series A raise in 2023, and accelerates our business development pipeline.

https://eos-advisory.com

for the press release see:

https://www.scotsman.com/business/perthshire-start-up-behind-game-changing-self-cleaning-tech-gets-ps1-million-injection-3830928

Penrhos Bio has become a member of the National Biofilms Innovation Centre, a world leading Innovation Knowledge Centre connecting scientists and industrial partners specialising in Biofilms from across the UK. Jointly funded by the BBSRC, Innovate UK, and the Hartree Centre, NBIC creates a fusion of world class interdisciplinary research and industry partnerships, and gives Penrhos Bio further access to researchers, funding opportunities and potential commercial partners in the field of anti-biofilm technology. NBIC is also highly influential in raising public awareness of the importance of biofilms through their public engagement and outreach activities. Penrhos Bio is looking forward to being an active and engaged member of the Centre, and contributing to its activities. Through this engagement, we also aim to deliver significant and impactful innovations for society.

https://www.biofilms.ac.uk/